CAS: 1776055-05-0

ML233 is a molecule that has been shown to have stem cell-like properties. It has been shown to promote the regeneration of retinal neurons and ganglion cells, preventing neuronal death in animal models with ischemia reperfusion injury. ML233 has also been shown to inhibit the proliferation of cancer cells and reduce inflammation in animal models. This molecule is conjugated to an antigen or antibody and administered intravitreally, where it can be delivered directly to the retina without entering systemic circulation.

ML230 is a selective ATP-binding cassette (ABC) transporter ABCG2 inhibitor.